Royal Fund Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-49
Closed -$3K 288
2020
Q1
$3K Sell
49
-5,316
-99% -$432K ﹤0.01% 457
2019
Q4
$451K Buy
5,365
+5,303
+8,553% +$420K 0.11% 89
2019
Q3
$4K Buy
62
+13
+27% +$991 ﹤0.01% 463
2019
Q2
$3K Sell
49
-7,767
-99% -$577K ﹤0.01% 470
2019
Q1
$597K Sell
7,816
-3,637
-32% -$271K 0.19% 69
2018
Q4
$788K Buy
11,453
+1,774
+18% +$134K 0.32% 60
2018
Q3
$821K Buy
9,679
+9,456
+4,240% +$755K 0.26% 66
2018
Q2
$16K Hold
223
0.01% 305
2018
Q1
$15K Hold
223
0.01% 303
2017
Q4
$15K Hold
223
0.01% 319
2017
Q3
$15K Hold
223
0.01% 271
2017
Q2
$14K Hold
223
0.01% 246
2017
Q1
$13K Hold
223
0.01% 247
2016
Q4
$12K Buy
+223
New +$12.9K 0.01% 242

Other funds holding FXH

Royal Fund Management's FXH Position: Q2 2020 in Review

Royal Fund Management sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q2 2020, closing a stake of 49 shares — an estimated $3K sold.

Royal Fund Management first reported a position in FXH in Q4 2016 and held it in 14 quarters. The position peaked at $821K in Q3 2018. 202 funds tracked by Wall St. Rank hold FXH as of Q2 2020.

  • Royal Fund Management reported no remaining First Trust Health Care AlphaDEX Fund position as of Q2 2020 after selling out during the quarter.
  • Royal Fund Management sold 49 First Trust Health Care AlphaDEX Fund shares in Q2 2020, an estimated $3K.
  • Royal Fund Management first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2016 and held it in 14 quarters.
  • Royal Fund Management's First Trust Health Care AlphaDEX Fund position peaked at $821K in Q3 2018.
  • 202 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.